Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion description "[In addition, immunohistochemical studies on mouse tumors injected with cisplatin or paclitaxel treated residual cells displayed higher staining for the proliferative antigen Ki67, oncogeneic CA125, epithelial E-cadherin as well as cancer stem cell markers such as Oct4 and CD117, compared to mice injected with control untreated cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion evidence source_evidence_literature NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion SIO_000772 23537295 NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion wasDerivedFrom befree-20150227 NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_assertion wasGeneratedBy ECO_0000203 NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP525996.RAOTVJwHD2OS3ZFCcHFrSS_MOSPm10VehD13TcMpuq-Tc130_provenance.